Prospective, open, single-arm clinical study of novel oncolytic virus against CTC micrometastasis of lung cancer, colorectal cancer and other malignant tumors

ABSTRACT: Interventions: Lung Cancer group:Novel Oncolytic Virus;Colorectal Cancer group:Novel Oncolytic Virus Primary outcome(s): objective response rate;overall survival;Quality of life;Safety;disease control rate;disease-free survival Study Design: Single arm

DISEASE(S): Lung Cancer, Colorectal Cancer Etal

PROVIDER: 2725682 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR